Skip to main content
logo
Boston Scientific Corporation (LON:0HOY)
London flag London · Delayed Price · Currency is GBP · Price in USD
75.27
-0.84 (-1.10%)
Feb 20, 2026, 4:54 PM GMT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg Revenue
6.82B5.99B
MedSurg Revenue Growth
13.87%10.53%
Cardiovascular Revenue
13.25B10.76B
Cardiovascular Revenue Growth
23.20%21.95%
Revenue (Other)
--1.00M
Revenue (Total)
20.07B16.75B
Revenue (Total) Growth
19.87%17.61%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
U.S Revenue
12.86B10.21B
U.S Revenue Growth
25.99%21.19%
Europe, Middle East and Africa Revenue
3.45B3.23B
Europe, Middle East and Africa Revenue Growth
6.91%13.03%
Asia-Pacific Revenue
3.08B2.69B
Asia-Pacific Revenue Growth
14.67%11.92%
Latin America and Canada Revenue
678.00M624.00M
Latin America and Canada Revenue Growth
8.65%11.43%
Revenue (Other)
1.00M-1.00M
Revenue (Total)
20.07B16.75B
Revenue (Total) Growth
19.87%17.61%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg Organic Revenue Growth
6.70%7.50%
Cardiovascular Organic Revenue Growth
20.80%21.90%
Total Organic Revenue Growth
15.80%16.40%
Updated Dec 31, 2025. Data Source: Fiscal.ai.